do not combine dpp-4 inhibitors with glp-1 receptor agonists guideline SGLT2 and in Diabetic Kidney Disease: Evolving Evidence and Clinical Application GLP 1 Receptor Agonists and
Description
This is fundamentally different from how GLP-1 medications are dosed

These agents delay gastric emptying which makes patients feel fuller for longer

If so, do you have a suggestion for a medication that would be a good candidate to make the switch

Retatrutide treats this condition by correcting hormonal imbalances
Diabetes, Obesity & Metabolism
